CHIMERIX, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.786 EUR | -0.63% |
|
-5.72% | -2.90% |
| 05-01 | Transcript : Chimerix, Inc., Q1 2024 Earnings Call, May 01, 2024 | |
| 05-01 | Chimerix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Chimerix, Inc.
91a.Qti3-yIsz6kf5igjy_eW8NLAQLCt0pHwmrldAClfXt8.GLDDsFJBpMxYskZXqrHfvLaNA8eendia898qX0QJZ-014PayFhS1_2WVaQ~4cb46f6807501b9a909efc2a3b01001b
Upcoming events on Chimerix, Inc.
Past events on Chimerix, Inc.
| 20/06/2024 13:00 | Annual General Meeting |
| 06/06/2024 20:00 | Jefferies Global Healthcare Conference |
| 01/05/2024 13:30 | Q1 2024 Earnings Call |
| 01/05/2024 12:00 | Q1 2024 Earnings Release |
| 05/03/2024 17:50 | TD Cowen Health Care Conference - Panel |
| 29/02/2024 13:30 | Q4 2023 Earnings Call |
| 29/02/2024 12:00 | Q4 2023 Earnings Release |
| 02/11/2023 12:30 | Q3 2023 Earnings Call |
| 02/11/2023 11:00 | Q3 2023 Earnings Release |
| 12/09/2023 | Baird Global Healthcare Conference |
| 12/09/2023 14:00 | H.C. Wainwright Global Investment Conference |
| 03/08/2023 13:30 | Q2 2023 Earnings Call |
| 03/08/2023 12:00 | Q2 2023 Earnings Release |
| 09/06/2023 13:00 | Annual General Meeting |
| 07/06/2023 20:30 | Jefferies Global Healthcare Conference |
| 24/05/2023 | Cancer Moonshot Brain Cancer Forum |
| 04/05/2023 13:30 | Q1 2023 Earnings Call |
| 04/05/2023 12:00 | Q1 2023 Earnings Release |
| 13/04/2023 | American Association for Cancer Research Meeting |
| 07/03/2023 19:10 | Cowen Health Care Conference - Panel |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 12,5 6,53 91.83% | 5,37 5,80 -7.38% | 1,98 19,6 -89.91% | 33,8 33,6 0.7% | 0,32 0,38 -14.02% | 6,16 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -116 -90,3 -28.4% | -44,5 -45,0 1.08% | -90,5 -138 34.32% | -60,4 -58,4 -3.35% | -93,1 -94,3 1.29% | -87,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -113 -55,5 -102.84% | -43,5 -43,6 0.18% | -173 -129 -34.68% | 172 172 0.19% | -82,1 -84,3 2.64% | -77,5 |
|
Net income Million USD | Released Forecast Spread | -113 -87,0 -29.47% | -43,5 -43,6 0.18% | -173 -138 -25.95% | 172 172 0.26% | -82,1 -84,3 2.64% | -79,0 |
|
EPS USD | Released Forecast Spread | -2,03 -1,57 -29.71% | -0,70 -0,70 0% | -2,04 -1,62 -26.08% | 1,94 1,95 -0.31% | -0,93 -0,95 2.11% | -0,88 |
| Announcement Date | 25/02/20 | 25/02/21 | 01/03/22 | 02/03/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | Dezember | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,02 0,00 3650% | 0,44 0,03 1642.57% | 32,6 218 -85.08% | 0,81 0,58 40.34% | 0,28 0,13 117.69% | 0,03 0,27 -90.33% | 0,01 0,09 -87.66% | 0,00 0,07 -94.15% | 0,00 0,06 - | 0,26 | 0,26 | 9,43 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -24,8 -33,5 25.96% | -23,4 -21,0 -11.88% | 11,6 240 -95.16% | -23,8 -21,9 -8.97% | -24,2 -22,0 -10.32% | -21,3 -22,2 3.76% | -26,7 -21,2 -25.8% | -20,8 -22,0 5.44% | -24,4 -21,8 -12.06% | -23,4 | -23,8 | -15,3 | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -24,8 -33,3 25.73% | -23,5 -20,5 -14.2% | 242 173 39.91% | -21,1 -21,4 1.56% | -21,4 -21,0 -1.76% | -18,6 -21,1 11.8% | -24,0 -19,9 -20.72% | -18,2 -20,3 10.6% | -21,9 -19,1 -14.2% | -21,4 | -21,8 | -13,9 | ||
|
Net income Million USD | Released Forecast Spread | -24,8 -30,6 19.18% | -23,5 -20,9 -12.32% | 241 186 29.82% | -21,0 -21,4 2.11% | -21,4 -21,0 -1.76% | -18,6 -21,1 11.8% | -24,0 -19,9 -20.72% | -18,2 -20,3 10.6% | -21,9 -19,1 -14.2% | -21,4 | -21,8 | -13,9 | ||
|
EPS USD | Released Forecast Spread | -0,28 -0,35 20.9% | -0,27 -0,24 -12.5% | 2,75 2,10 30.95% | -0,24 -0,24 0.83% | -0,24 -0,24 1.64% | -0,21 -0,24 11.89% | -0,27 -0,23 -20% | -0,20 -0,23 13.04% | -0,25 -0,22 -16.28% | -0,23 | -0,24 | -0,16 | -0,23 | -0,24 |
| Announcement Date | 16/05/22 | 08/08/22 | 03/11/22 | 02/03/23 | 04/05/23 | 03/08/23 | 02/11/23 | 29/02/24 | 01/05/24 | - | - | - | - | - |
More events
Past sector events for Chimerix, Inc.
| 05/06/2024 08:51 | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
| 17/05/2024 12:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 16/05/2024 12:46 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 06:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 15/05/2024 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 15/05/2024 13:05 | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 15/05/2024 12:00 | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 14/05/2024 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 14/05/2024 21:05 | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 21:00 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CMRX Stock
- CXF Stock
- Calendar Chimerix, Inc.
